Public Notifications

Search

Search Results

Search Again
Djavanmardi, Mansour/Native Vancouver Pharmacy (May 29, 2015)
(September 3, 2015 - Mansour Djavanmardi – Limits and conditions removed)

On May 27, 2015, pursuant to s. 20(3) of the Pharmacy Operations and Drug Scheduling Act, S.B.C. 2003, c. 77 and s. 35(1)(b) of the Health Professions Act, R.S.B.C. 1996, c. 183, the Inquiry Committee made an extraordinary order to suspend the pharmacy license of Native Vancouver Pharmacy, located at 108-50 East Hastings Street in Vancouver, pending completion of an investigation. This order was made in the interest of public safety following an inspection of the pharmacy by College inspectors, which raised serious concerns with respect to unhygienic conditions of the pharmacy, and the suitability of the premises to continue operating as a pharmacy. Examples of such conditions include, but are not limited to:

  • Mould found on the floors, walls, and food containers inside the dispensary
  • Fecal matter from mice and rats on the floor and other surfaces
  • Mouse and cockroach bait traps found in numerous locations within dispensary
  • Food, sugar, and coffee whitener left out in the open in the dispensary, accessible to insects and rodents
  • No hot running water
  • Dirty and dilapidated interior walls, fixtures, and furniture

The suspension will be effective as of June 12, 2015 and will continue until further notice. The Inquiry Committee, pursuant to s. 35(1)(a) of the Health Professions Act, for the purposes of public protection, also imposed limits and conditions on the practice of registrant Mansour Djavanmardi, the pharmacy manager of Native Vancouver Pharmacy, in that he may not be a pharmacy manager, effective June 12, 2015 pending completion of an investigation.

Pharmacist Registrant 20 (Feb 18, 2015)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with the pharmacist registrant to suspend his registration as a pharmacist effective February 18, 2015. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pharmacist Registrant 3 (Dec 22, 2014)

Pharmacist registrant has satisfied the terms of an agreement reached with the Inquiry Committee dated December 21, 2009.  Limits and conditions on pharmacist registrant’s registration as a pharmacist have now been removed.  The pharmacist registrant’s name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pharmacist Registrant 20 (Nov 17, 2014)
(February 18, 2015 - Registration Suspended)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with the pharmacist registrant whereby the registrant consented to undertakings involving regular monitoring for fitness to practice pharmacy. The undertakings include, but are not limited to:

  1. Routine and random medical monitoring;

  2. Informing all managers and employers with whom he gains employment of his medical condition and the need to maintain vigilance with respect to recovery and the possibility of relapse, and the limits and conditions on his registration pursuant to the agreement;

  3. Ensuring that all managers and employers with whom he gains employment submits a written statement to the College declaring their awareness of his medical condition and the agreement;

  4. To return to work gradually, in accordance with the recommendations of his physician;

  5. To only be involved in the dispensing, ordering, contact, destruction, counting or otherwise handling of opiate and benzodiazepine type medications as long as a pharmacy assistant and/or pharmacy technician is also on duty at the same time and he takes oral Naltrexone (Revia) 50mg every day, witnessed by a pharmacy staff member at a pharmacy that agrees to perform this service, and that the pharmacy send the College written confirmation every month that the Registrant has done so, and the pharmacy is to contact the College immediately if there is any non-compliance by the Registrant.

  6. Being restricted from the following roles in his practice:

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor.

     

  7. Notifying the College of:

    1. all changes in his places of employment as a pharmacist
    2. all changes in residential address and phone number; and
    3. all changes in medical provider.

The agreement will remain in place for a minimum of five years of continuous pharmacy practice. The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public.

Doan, Khiem Ngoc (Nov 10, 2014)

Pursuant to section 36 of the Health Professions Act, the Inquiry Committee has reached an agreement with registrant Khiem Doan to change his registration status to Former Pharmacist and is no longer a registrant of the College.  The registrant has agreed that he will not in future apply for registration or reinstatement to the College or apply for registration in any capacity by a governing body for a pharmacy in another province or foreign jurisdiction.

Lewis, Christopher James (Aug 23, 2014)
(AUGUST 24, 2015 – LIMITS AND CONDITIONS REMOVED)

Christopher James Lewis has completed a term of suspension which ended on August 22, 2014, and his registration has been reinstated as of August 23, 2014.

Pharmacist Registrant 17 (Jul 24, 2014)
(JULY 24, 2016 – LIMITS AND CONDITIONS REMOVED)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with the pharmacist registrant whereby the registrant consented to undertakings involving regular monitoring for fitness to practice pharmacy. The undertakings include, but are not limited to:

  1. Routine and random medical monitoring;

  2. Informing all managers and employers with whom he gains employment of his medical condition and the need to maintain vigilance with respect to recovery and the possibility of relapse, and the limits and conditions on his registration pursuant to the agreement;

  3. Ensuring that all managers and employers with whom he gains employment submits a written statement to the College declaring their awareness of his medical condition and the agreement;

  4. Not being involved in the dispensing, ordering, contact, destruction, counting or otherwise handling of opiate medications and other medications with abusive potential, including benzodiazepines, stimulants and sedative medications such as Zopiclone;

  5. Being restricted from the following roles in his practice:

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor.

     

  6. Notifying the College of:

    1. all changes in his places of employment as a pharmacist
    2. all changes in residential address and phone number; and
    3. all changes in medical provider.

     

The agreement will remain in place for a minimum of two years of continuous pharmacy practice. The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public.

Ladha, Aziza (Jul 10, 2014)

Aziza Ladha has satisfied the terms of an agreement reached with the Inquiry Committee dated July 10, 2012. Limits and conditions on Ms. Ladha’s registration as a pharmacist have now been removed.

Ghag, Sukhvinder (Jun 30, 2014)

Sukhvinder has satisfied the terms of an agreement reached with the Inquiry Committee dated July 17, 2013. Limits and conditions on Mr. Ghag’s registration as a pharmacist have now been removed.

Ghag, Amrik (Jun 30, 2014)

Amrik Ghag has satisfied the terms of an agreement reached with the Inquiry Committee dated July 17, 2013. Limits and conditions on Mr. Ghag’s registration as a pharmacist have now been removed.

Pages